Medical Liquid Oxygen Air Liquide Healthcare Ireland

Oxygen, the active ingredient in Medical Liquid Oxygen Air Liquide Healthcare Ireland, is a medical gas presented as liquid oxygen for inhalation use. It supplies supplemental oxygen to increase arterial oxygen tension and improve tissue oxygenation in patients with hypoxemia and related respiratory conditions.

GNH USA supplies Medical Liquid Oxygen Air Liquide Healthcare Ireland as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Medical Liquid Oxygen provides supplemental oxygen for disorders affecting the respiratory system and tissue oxygenation.

- Hypoxemia: restores adequate arterial oxygen levels to support cellular metabolism. - Respiratory distress: alleviates low oxygen saturation during acute breathing difficulties. - Chronic obstructive pulmonary disease (COPD): improves exercise tolerance and reduces dyspnoea. - Post‑operative oxygen therapy: maintains optimal oxygenation during recovery after surgery.

Adverse reactions may occur with any supplemental oxygen therapy.

Common Side Effects: - Nasal dryness or irritation - Throat discomfort - Headache - Fatigue - Coughing - Dizziness

Serious or Rare Side Effects: - Pulmonary oxygen toxicity (e.g., atelectasis, fibrosis) - Central nervous system oxygen toxicity (seizures) - Fire or explosion hazard in the presence of flammable materials - Chest pain or worsening dyspnoea due to hyperoxia - Vision changes (retinopathy) with prolonged high‑concentration exposure

When using Medical Liquid Oxygen, consider the following safety measures.

- Patient assessment: evaluate baseline oxygen saturation and underlying lung disease before initiation. - Monitoring: continuously monitor SpO₂ and adjust flow to maintain target levels. - Fire safety: keep away from open flames, sparks, and smoking materials. - Equipment check: ensure delivery devices are compatible and free of leaks. - Storage at low temperature: keep in approved cryogenic container, protect from heat and direct sunlight.

Oxygen therapy can interact with certain agents and environmental conditions.

Major Interactions (Avoid): - Nitrous oxide: combined use may increase risk of pulmonary toxicity. - High‑fraction diving gases: can cause central nervous system oxygen toxicity. - Certain chemotherapeutics (e.g., doxorubicin): may enhance oxidative stress.

Moderate Interactions (Monitor Closely): - Bronchodilators: may potentiate respiratory response, monitor for over‑oxygenation. - Sedatives or opioids: can depress respiratory drive, require close SpO₂ monitoring. - Carbon monoxide exposure: oxygen therapy is essential but CO levels must be tracked.